BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Kenpaullone

kenpaullone [Supplementary Concept] inhibits CDK1/cyclin B; structure in first source Heading Mapped to: Benzazepines Indoles

8+ PubMed studies analyzed · Evidence Score: 22.3

Research Domains

Kenpaullone has been studied across 8 research domains including 🔬 Oncology, 🧠 Neuroprotection, 🧠 Memory, 🧠 Learning, 🔬 Inflammation. The primary research focus is 🔬 Oncology with 50% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Kenpaullone, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

alsterpaullone
45 shared targets
sp600125
43 shared targets
tyrphostin
20 shared targets
fisetin
17 shared targets
Niclosamide
22 shared targets
indirubin
12 shared targets
Luteolin
27 shared targets
defactinib
17 shared targets
Apigenin
26 shared targets
chrysin
20 shared targets
Loading evidence profile...

This evidence profile for Kenpaullone is generated deterministically from 8 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.